Skip to main content
Premium Trial:

Request an Annual Quote

Arthur Grossman, Chung-Soon Im

Premium
Solazyme has appointed Arthur Grossman as chief of genetics, the Menlo Park, Calif.-based company said last week. Grossman is a senior staff scientist at the Carnegie Institution and a professor of biological sciences at Stanford University.
 
Solazyme said Grossman will retain his academic positions but will split time with the company. At Solazyme, Grossman will oversee R&D projects and development strategies. He was formerly chair of Solazyme’s scientific advisory board.
 
In addition, Chung-Soon Im has joined Solazyme as a scientist. According to the firm, Im is an algal geneticist with expertise in the areas of algal genetic engineering, algal microarray technology, and the characterization of genetic pathways involved in the biosynthesis of high value algal materials.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.